DM
Drugs Made In America Acquisition II Corp. Right (DMIIR)
NASDAQ·Financial Services·Asset Management
$0.07
+0.00%
Mkt Cap $8.52M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$230.00
Range $156.00 – $270.00
Implied Upside
+328471.4%
Consensus $230.00 vs current $0.07